Brokers Offer Predictions for Core Scientific Q2 Earnings

Core Scientific, Inc. (NASDAQ:CORZ) – Roth Capital lowered their Q2 2026 earnings per share estimates for Core Scientific in a research note issued on Thursday, May 8th. Roth Capital analyst D. Aftahi now expects that the company will post earnings per share of $0.01 for the quarter, down from their prior estimate of $0.02. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2026 earnings at $0.03 EPS, FY2026 earnings at $0.05 EPS, FY2027 earnings at $0.17 EPS and FY2028 earnings at $0.86 EPS.

Other equities research analysts also recently issued research reports about the stock. Compass Point lowered their price objective on shares of Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research report on Tuesday, February 25th. Keefe, Bruyette & Woods began coverage on Core Scientific in a report on Monday, January 27th. They set an “outperform” rating and a $22.00 target price for the company. Cantor Fitzgerald cut their price target on Core Scientific from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Needham & Company LLC lowered their price objective on Core Scientific from $18.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, February 27th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 target price on shares of Core Scientific in a research note on Friday. Fifteen equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $19.07.

Core Scientific Price Performance

Core Scientific stock opened at $9.32 on Friday. The company has a market cap of $2.75 billion, a PE ratio of -1.72 and a beta of 6.66. Core Scientific has a 12 month low of $3.46 and a 12 month high of $18.63. The company has a fifty day moving average price of $7.92 and a two-hundred day moving average price of $12.09.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, May 7th. The company reported ($0.10) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.02. The firm had revenue of $79.53 million during the quarter, compared to analyst estimates of $92.04 million. Core Scientific’s revenue was down 55.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.78 EPS.

Insiders Place Their Bets

In other Core Scientific news, Director Todd A. Becker sold 134,250 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares in the company, valued at approximately $2,103,635.25. The trade was a 40.69 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jordan Levy acquired 62,500 shares of Core Scientific stock in a transaction dated Thursday, March 6th. The shares were acquired at an average price of $8.01 per share, with a total value of $500,625.00. Following the transaction, the director now owns 306,887 shares in the company, valued at approximately $2,458,164.87. This represents a 25.57 % increase in their position. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by insiders.

Institutional Trading of Core Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. grew its position in Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock worth $5,192,000 after buying an additional 142,068 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Core Scientific by 25.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock worth $1,378,000 after acquiring an additional 20,000 shares during the last quarter. ORG Wealth Partners LLC raised its position in shares of Core Scientific by 0.3% during the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after purchasing an additional 26,649 shares during the period. FNY Investment Advisers LLC lifted its holdings in shares of Core Scientific by 35.8% during the fourth quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company’s stock valued at $2,679,000 after purchasing an additional 50,275 shares during the last quarter. Finally, Shikiar Asset Management Inc. boosted its position in shares of Core Scientific by 27.0% in the 4th quarter. Shikiar Asset Management Inc. now owns 95,250 shares of the company’s stock valued at $1,338,000 after purchasing an additional 20,250 shares during the period.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.